Gene Therapy, Luxturna (Voretigene Neparvovec-rzyl), Approved for Rare Inherited Vision-Loss Disorders

TUESDAY, Dec. 19, 2017 — Luxturna, a form of gene therapy, has been approved to treat a rare group of inherited vision disorders that can lead to blindness.
The disorders are broadly grouped together and known as biallelic RPE65…
Source: Topamax